Clinical Trials Directory

Trials / Terminated

TerminatedNCT00482742

Safety & Performance Randomized Study of the CiTop™ Guidewire for Peripheral CTO

A Feasibility, Multi Center Multinational Randomized Open Label Study, to Evaluate the Safety and Performance of the CiTop™ Guidewire for Crossing Total Occlusion in Peripheral Arteries.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Ovalum · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The main objectives of the study are: To evaluate the performance and safety of the CiTop guidewire, while attempting to cross thru total occlusions of various dimensions and morphology. To compare the safety and efficacy of the CiTop guidewire with standard guidewires in terms of impact on the treated artery. Following operation of the CiTop device, angiography demonstrated successful crossing of the occlusion with no visible evidence of arterial wall injury, dissection, or distal embolization. To assess ease of operation and the level of integration of the CiTop with standard interventional angiography procedure: Balloon angioplasty, placement of stent.

Conditions

Interventions

TypeNameDescription
DEVICECiTop(TM) Guidewire

Timeline

Start date
2006-10-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2007-06-05
Last updated
2013-07-09

Locations

3 sites across 2 countries: Croatia, Israel

Source: ClinicalTrials.gov record NCT00482742. Inclusion in this directory is not an endorsement.